|
Although kinase inhibitors raise hope for people with cancer, patients and
their clinicians are commonly confronted with the cutaneous side-effects that
are associated with the use of these drugs. This review is the result of
collaborations between dermatologists, medical oncologists, and pathologists,
and discusses the cutaneous side-effects seen after treatment with the
inhibitors of epidermal-growth-factor receptor (EGFR), imatinib, sorafenib, and
sunitinib.
New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML YAHOO! GROUPS LINKS
|
